mk-0482
mAbexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 19, 2019 (NCT03918278)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06413095 | Early Phase 1 (Phase 1) | Jun 1, 2022 | Merck, Presage Biosciences |
| NCT05038800 | Phase 1 | Sep 26, 2021 | Merck |
| NCT03918278 | Phase 1 | Jun 19, 2019 | Merck |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Merck | For profit | 3 | 2 | 1 | 2019 |
| Presage Biosciences | For profit | 1 | 1 | 1 | 2022 |
2 organizations
Page 1 / 1